Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; and products for surgical treatment of tumors or vascular diseases, such as aneurysms. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Industry, Sector and Symbol
Stock Exchange ETR
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
SymbolETR:AFX
CUSIPN/A
Phone+49-3641-2200
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins9.50%
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares81,310,000
Market Cap$4.49 billion
Carl Zeiss Meditec (ETR:AFX) Frequently Asked Questions
What is Carl Zeiss Meditec's stock symbol?
Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."
What price target have analysts set for AFX?
9 brokerages have issued 12 month target prices for Carl Zeiss Meditec's stock. Their forecasts range from €48.50 to €73.00. On average, they expect Carl Zeiss Meditec's stock price to reach €59.75 in the next year. This suggests that the stock has a possible downside of 18.2%. View Analyst Price Targets for Carl Zeiss Meditec.
What is the consensus analysts' recommendation for Carl Zeiss Meditec?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 1 sell rating and 8 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Carl Zeiss Meditec.
Who are some of Carl Zeiss Meditec's key competitors?
Some companies that are related to Carl Zeiss Meditec include Sartorius AG Preference Shares (SRT3), Senseonics (SENS), MaxCyte (MXCT), Palatin Technologies (PTN), EPIGENOMICS AG/S (EPGNY), Oncimmune (ONC), Profound Medical (PRN), Lexagene (LXG), Sernova (SVA), Co-Diagnostics (CODX), SQI Diagnostics (SQD), Parallax Health Sciences (PRLX), Cambridge Cognition (COG), LED Medical Diagnostics (LMD) and 3D Signatures (DXD).
Who are Carl Zeiss Meditec's key executives?
Carl Zeiss Meditec's management team includes the folowing people:
- Dr. Ludwin Monz Ph.D., M.B.A., Pres, CEO & Chairman of Management Board (Age 55)
- Dr. Christian Muller Dipl.-Kaufmann, M.B.A., CFO & Member of the Management Board (Age 51)
- Mr. Sebastian Frericks, Director of Investor Relations
- Mr. Martin Wiechmann, Head of the Planetarium Bus. Unit
- Mr. Mike Wang, Head of Marketing - Shanghai
Has Carl Zeiss Meditec been receiving favorable news coverage?
Press coverage about AFX stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Carl Zeiss Meditec earned a news impact score of 0.08 on Accern's scale. They also assigned media stories about the company an impact score of 47.33 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. View Recent Headlines for Carl Zeiss Meditec.
What is Carl Zeiss Meditec's stock price today?
One share of AFX stock can currently be purchased for approximately €73.00.
How big of a company is Carl Zeiss Meditec?
Carl Zeiss Meditec has a market capitalization of $4.49 billion.
How can I contact Carl Zeiss Meditec?
Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The company can be reached via phone at +49-3641-2200.
MarketBeat Community Rating for Carl Zeiss Meditec (ETR AFX)
MarketBeat's community ratings are surveys of what our community members think about Carl Zeiss Meditec and other stocks. Vote "Outperform" if you believe AFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
